• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    5/29/24 1:28:35 PM ET
    $AAL
    $AAP
    $ANF
    $ASTI
    Air Freight/Delivery Services
    Consumer Discretionary
    Auto & Home Supply Stores
    Consumer Discretionary
    Get the next $AAL alert in real time by email

    Shares of Bank of Montreal (NYSE:BMO) fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter financial results.

    Bank of Montreal posted quarterly adjusted earnings of C$2.59 per share, missing market estimates of C$2.77 per share. The company's quarterly sales came in at C$7.988 billion missing expectations of C$8.046 billion, according to data from Benzinga Pro.

    Bank of Montreal shares declined 7.1% to $89.32 on Wednesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • ReShape Lifesciences Inc. (NASDAQ:RSLS) shares jumped 82.8% to $0.3799 a day after it received the nod from the U.S. Patent And Trademark Office to issue a patent for its obesity treatment.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) shares jumped 56.1% to $0.64 after the company launched its Eddie Bauer Smart Eyewear collection.
    • Brand Engagement Network, Inc. (NASDAQ:BNAI) climbed 41% to $1.7900 after the company announced a $4.95 million private placement and appointed Paul Chang to co-CEO.
    • Siyata Mobile Inc. (NASDAQ:SYTA) gained 40% to $2.10. The company yesterday announced that it received an order from the City of Lancaster Public Utilities Department for its SD7 Push-to-Talk handsets, VK7 Vehicle Kits and related accessories.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) climbed 29% to $6.88 after the company announced a partnership with Verizon for direct-to-cellular AST SpaceMobile service when needed for Verizon customers.
    • Cheche Group Inc. (NASDAQ:CCG) shares gained 25.4% to $1.67. Cheche Group is expected to host a conference call to discuss first quarter 2024 results on Thursday, May 30.
    • Mustang Bio, Inc. (NASDAQ:MBIO) gained 25% to $0.2370.
    • Globavend Holdings Limited (NASDAQ:GVH) jumped 23.5% to $1.89 after the company announced an MOU to acquire Top Logistics.
    • Ikena Oncology, Inc. (NASDAQ:IKNA) gained 22.5% to $1.63 after the company announced it will discontinue development of IK-930 and evaluate strategic options for both the Company and its development pipeline.
    • Ooma, Inc. (NYSE:OOMA) rose 22.3% to $9.66 after the company reported better-than-expected first-quarter financial results and issued strong guidance for the second quarter.
    • Tantech Holdings Ltd (NASDAQ:TANH) jumped 22% to $0.80. Tantech recently received a notice of non-compliance from the Nasdaq.
    • Chewy, Inc. (NYSE:CHWY) rose 21.5% to $20.54 following better-than-expected first-quarter earnings.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) gained 21.1% to $5.96.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) climbed 21% to $0.2290.
    • Surmodics, Inc. (NASDAQ:SRDX) gained 20.3% to $42.23 after the company announced it will be acquired by GTCR for $43 per share in cash for a total equity valuation of roughly $627 million.
    • Abercrombie & Fitch Co. (NYSE:ANF) gained 15.9% to $176.57 following better-than-expected first-quarter financial results.
    • DICK’S Sporting Goods, Inc. (NYSE:DKS) rose 15.8% to $225.87 as the company reported better-than-expected first-quarter FY24 earnings and raised the outlook.
    • Semler Scientific, Inc. (NASDAQ:SMLR) rose 14.8% to $33.28. The company recently announced that its board of directors adopted bitcoin as its primary treasury reserve asset.
    • Scorpius Holdings, Inc. (NYSE:SCPX) shares gained 14.2% to $0.1279 after gaining 6% on Tuesday.
    • Banzai International, Inc. (NASDAQ:BNZI) gained 13.5% to $0.1989. Banzai, last week, announced the pricing of a $2.5 million public offering.
    • Neonode Inc. (NASDAQ:NEON) jumped 12.9% to $3.2746.
    • Gyre Therapeutics, Inc. (NASDAQ:GYRE) jumped 12.3% to $11.40. Gyre Therapeutics announced expected addition to the Russell 2000® and Russell 3000® Indexes.
    • Immunovant, Inc. (NASDAQ:IMVT) rose 11.3% to $31.66.
    • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) gained 11.2% to $0.1660 following a 3% decline on Tuesday.
    • Box, Inc. (NYSE:BOX) rose 9.1% to $27.30 as the company reported its first-quarter financial results.
    • Titan Machinery Inc. (NASDAQ:TITN) gained 8.2% to $19.18.

    Losers

    • Faraday Future Intelligent Electric Inc (NASDAQ:FFIE) fell 38.8% to $0.7232. Faraday Future's annual report for fiscal year 2023 showed a revenue of $0.8 million, significantly below analyst estimates of $2.59 million. While the net loss narrowed from $602 million in 2022 to $432 million in 2023, it still paints a concerning financial picture.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares fell 37% to $5.74. AERWINS Technologies shares jumped 143% on Tuesday after the company reported a year-over-year increase in first-quarter EPS results.
    • SOBR Safe, Inc. (NASDAQ:SOBR) shares fell 32% to $0.2889 after jumping 84% on Monday.
    • Cue Health Inc. (NASDAQ:HLTH) shares dipped 29.1% to $0.0643 after the company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business.
    • Sharps Technology, Inc. (NASDAQ:STSS) shares declined 26.4% to $0.3810 after surging 141% on Tuesday. In an exchange filing, the company said it has entered into a series of agreements with Nephron SC and Nephron Sterile Compounding Centers.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) fell 23.8% to $0.8073.
    • Genetic Technologies Limited (NASDAQ:GENE) declined 18.4% to $1.7301. GTG launched revolutionary geneType test covering 100% risk of breast and ovarian cancer.
    • CN Energy Group. Inc. (NASDAQ:CNEY) dipped 18% to $0.51.
    • Predictive Oncology Inc. (NASDAQ:POAI) fell 17.6% to $1.72. Predictive Oncology shares surged 31% on Tuesday after the company announced results from its ovarian caner study with UPMC Magee-Womens Hospital.
    • Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) dropped 15.3% to $9.15.
    • American Airlines Group Inc. (NASDAQ:AAL) shares declined 15.3% to $11.38 after the company announced the departure of its executive vice president and lowered guidance for the second quarter.
    • Bank OZK (NASDAQ:OZK) fell 15% to $39.30 after Citigroup downgraded the stock from Buy to Sell and lowered its price target from $57 to $37.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) dipped 15% to $0.0909.
    • Onfolio Holdings, Inc. (NASDAQ:ONFO) shares fell 14.3% to $1.13 in pre-market trading after jumping around 36% on Tuesday. Onfolio Holdings, last week, posted a quarterly loss of 14 cents per share.
    • Veru Inc. (NASDAQ:VERU) fell 13.1% to $0.9644.
    • Telephone and Data Systems, Inc. (NYSE:TDS) fell 9.3% to $17.31. JP Morgan analyst Sebastiano Petti maintained Telephone and Data with an Overweight and lowered the price target from $36 to $34.
    • Toast, Inc. (NYSE:TOST) fell 6.4% to $23.81.
    • Advance Auto Parts, Inc. (NYSE:AAP) fell 5.5% to $66.28 following quarterly earnings.
    • CAVA Group, Inc. (NYSE:CAVA) shares declined 4.2% to $78.92 following first-quarter results.

    Now Read This: Amazon, Target, Diamondback Energy And More On CNBC’s ‘Final Trades‘

    Get the next $AAL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAL
    $AAP
    $ANF
    $ASTI

    CompanyDatePrice TargetRatingAnalyst
    Toast Inc.
    $TOST
    3/31/2026$26.00Hold
    Loop Capital
    CAVA Group Inc.
    $CAVA
    3/30/2026$91.00Neutral
    BNP Paribas Exane
    CAVA Group Inc.
    $CAVA
    3/26/2026$100.00Buy
    Guggenheim
    Abercrombie & Fitch Company
    $ANF
    3/26/2026$108.00Buy
    Needham
    Box Inc.
    $BOX
    3/23/2026Outperform → Mkt Perform
    William Blair
    Immunovant Inc.
    $IMVT
    3/20/2026$28.00Mkt Perform
    Bernstein
    Bank Of Montreal
    $BMO
    3/20/2026Equal Weight → Underweight
    Barclays
    CAVA Group Inc.
    $CAVA
    3/9/2026$93.00Outperform
    Wolfe Research
    More analyst ratings

    $AAL
    $AAP
    $ANF
    $ASTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Vassil Jonathan

    4 - Toast, Inc. (0001650164) (Issuer)

    4/3/26 4:34:03 PM ET
    $TOST
    EDP Services
    Technology

    SEC Form 4 filed by Elworthy Brian R

    4 - Toast, Inc. (0001650164) (Issuer)

    4/3/26 4:33:31 PM ET
    $TOST
    EDP Services
    Technology

    SEC Form 4 filed by Venker Eric

    4 - Immunovant, Inc. (0001764013) (Issuer)

    4/3/26 4:33:01 PM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAL
    $AAP
    $ANF
    $ASTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Financial Officer Gayle Oswald bought $1,669 worth of shares (1,000 units at $1.67), increasing direct ownership by 54% to 2,865 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/15/26 5:00:07 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Chief Executive Officer Gross Harrison R. bought $2,400 worth of shares (1,500 units at $1.60), increasing direct ownership by 14% to 12,233 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/12/26 5:00:39 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $AAL
    $AAP
    $ANF
    $ASTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Loop Capital initiated coverage on Toast with a new price target

    Loop Capital initiated coverage of Toast with a rating of Hold and set a new price target of $26.00

    3/31/26 8:18:46 AM ET
    $TOST
    EDP Services
    Technology

    BNP Paribas Exane initiated coverage on CAVA Group with a new price target

    BNP Paribas Exane initiated coverage of CAVA Group with a rating of Neutral and set a new price target of $91.00

    3/30/26 8:17:53 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Guggenheim initiated coverage on CAVA Group with a new price target

    Guggenheim initiated coverage of CAVA Group with a rating of Buy and set a new price target of $100.00

    3/26/26 8:46:57 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    $AAL
    $AAP
    $ANF
    $ASTI
    SEC Filings

    View All

    SEC Form 10-K filed by Ooma Inc.

    10-K - OOMA INC (0001327688) (Filer)

    4/3/26 5:23:10 PM ET
    $OOMA
    EDP Services
    Technology

    SEC Form PRE 14A filed by Banzai International Inc.

    PRE 14A - Banzai International, Inc. (0001826011) (Filer)

    4/2/26 5:28:13 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by CN Energy Group Inc.

    6-K - CN ENERGY GROUP. INC. (0001780785) (Filer)

    4/2/26 5:15:06 PM ET
    $CNEY
    Major Chemicals
    Industrials

    $AAL
    $AAP
    $ANF
    $ASTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    Cheche Group Reports Second Half and Full Year 2025 Unaudited Financial Results

    BEIJING, April 2, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ:CCG) ("Cheche," "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the second half and full year ended December 31, 2025. Key Business HighlightsPartnerships with New Energy Vehicle (NEV) companies(1) reached 16 in the second half 2025 and led to 1.2 million policies with corresponding written premium of RMB3.7 billion (US$532.0 million), representing an increase of 61.8% and 63.9%, respectively, compared to the prior-year period. Embedded policies and corresponding written premium for the full year 2025 reached 2.0 million and RMB6.3 billion (US$902.1

    4/2/26 6:00:00 AM ET
    $CCG
    $NIO
    Specialty Insurers
    Finance
    Auto Manufacturing
    Industrials

    Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

    Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous findingsPatients in the TED studies demonstrated greater levels of proptosis improvement from baseline after the initial 12-week high-dose period than after the following 12-week low-dose period, supporting the benefit of deeper IgG suppression. The hyperthyroid patients in the TED studies showed similar response rates of thyroid hormone normalization to those seen in the batoclimab Phase 2 study in Graves' diseaseImmunovant remains focused on rapid advancement of IMVT-1402 in multiple indications DURHAM, N.C., April 02, 2026 (GLOBE NEWSWIRE)

    4/2/26 5:00:00 AM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAL
    $AAP
    $ANF
    $ASTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $AAP
    $ANF
    $ASTI
    Leadership Updates

    Live Leadership Updates

    View All

    Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner

    MIAMI, March 31, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, is pleased to announce the launch of the new Lucyd Armor® Vantage style. The new smart safety frame is fully certified for workplace use under US, Canadian and European standards. The frame will debut on March 31, 2026 at the National Hardware Show: Concept to Commerce event in Las Vegas. The frame will launch on the Company's website as well as with its new premier reseller for the safety channel, Ocusafe.com.

    3/31/26 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Eugene I. Lee, Jr. Appointed Chairman of the Board of Portillo's; Michael A. Miles, Jr. to Retire as of Annual Meeting

    CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Portillo's (NASDAQ:PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, today announced a leadership transition within its Board of Directors. The Board has appointed Eugene I. Lee, Jr., a respected veteran of the restaurant industry and award-winning foodservice leader, as Chairman of the Board, effective immediately. Lee succeeds Michael A. Miles, Jr., who will retire after leading the Company's Board of Directors since 2014, where he helped transition Portillo's from a founder-led company to a public company. "It's an honor to step into the role of Chairman at this pivotal time. Portillo's is an iconic bran

    3/11/26 8:15:00 AM ET
    $AAP
    $PTLO
    Auto & Home Supply Stores
    Consumer Discretionary
    Restaurants

    Advance Auto Parts Appoints Cynthia Jamison to Board of Directors

    Advance Auto Parts, Inc. (NYSE:AAP), a leading automotive aftermarket parts provider in North America announced today, that it has appointed Cynthia Jamison as an independent director to the Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310861689/en/Cynthia Jamison has been appointed as an independent director to Advance Auto Parts' Board of Directors. "Cynthia brings a wealth of Board and executive leadership experience within the retail and consumer products sectors, making her an invaluable addition to the Advance Board," said Gene Lee, chair of the board. "On behalf of the entire board of directors, I

    3/10/26 4:15:00 PM ET
    $AAP
    Auto & Home Supply Stores
    Consumer Discretionary

    $AAL
    $AAP
    $ANF
    $ASTI
    Financials

    Live finance-specific insights

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    Cheche Group Reports Second Half and Full Year 2025 Unaudited Financial Results

    BEIJING, April 2, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ:CCG) ("Cheche," "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the second half and full year ended December 31, 2025. Key Business HighlightsPartnerships with New Energy Vehicle (NEV) companies(1) reached 16 in the second half 2025 and led to 1.2 million policies with corresponding written premium of RMB3.7 billion (US$532.0 million), representing an increase of 61.8% and 63.9%, respectively, compared to the prior-year period. Embedded policies and corresponding written premium for the full year 2025 reached 2.0 million and RMB6.3 billion (US$902.1

    4/2/26 6:00:00 AM ET
    $CCG
    $NIO
    Specialty Insurers
    Finance
    Auto Manufacturing
    Industrials

    Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)

    Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous findingsPatients in the TED studies demonstrated greater levels of proptosis improvement from baseline after the initial 12-week high-dose period than after the following 12-week low-dose period, supporting the benefit of deeper IgG suppression. The hyperthyroid patients in the TED studies showed similar response rates of thyroid hormone normalization to those seen in the batoclimab Phase 2 study in Graves' diseaseImmunovant remains focused on rapid advancement of IMVT-1402 in multiple indications DURHAM, N.C., April 02, 2026 (GLOBE NEWSWIRE)

    4/2/26 5:00:00 AM ET
    $IMVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAL
    $AAP
    $ANF
    $ASTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care